June 29 – July 2, Hangzhou, Zhejiang. The 5th Qianjiang International Imaging Forum, sponsored by Radiology Committee of Zhejiang Biomedical Engineering Society, undertaken by the Second Affiliated Hospital of Zhejiang University School of Medicine and co-organized by Medical Artificial Intelligence Alliance, was grandly held in Hangzhou New Century Mingdu Hotel. Nearly a thousand radiology experts from home and abroad gathered together to share the hot topics in the industry such as China Brain Project, imaging omics, neuroscience, medical informatization, intelligent imaging and so on. Among the many keywords, “artificial intelligence” is undoubtedly the most popular one.
Giiso Information, founded in 2013, is a leading technology provider in the field of “artificial intelligence + information” in China, with top technologies in big data mining, intelligent semantics, knowledge mapping and other fields. At the same time, its research and development products include information robot, editing robot, writing robot and other artificial intelligence products! With its strong technical strength, the company has received angel round investment at the beginning of its establishment, and received pre-A round investment of $5 million from GSR Venture Capital in August 2015.
The number of cardiovascular patients in China has reached 290 million, including more than 13 million stroke patients, according to the China Cardiovascular Disease Report 2017 released by the National Cardiovascular Disease Center. Unfortunately, there are only 266 advanced stroke centers and construction units in China, and less than 2% of patients receive standardized first aid for stroke within one hour. More than 70% of patients lose their working ability to varying degrees, and about 40% of them are severely disabled.
As the hottest frontier technology, what is the future of medical AI? Can MEDICAL AI play a big role in stroke? Will medical AI become the infrastructure of the medical industry?
As the leader of domestic medical ARTIFICIAL intelligence technology and concept, Yitu Medical fully participated in and supported the Qianjiang International Video Forum, and sent 2 heavyweight guests to attend the forum. Respectively according to the figure of medical product marketing director wang wen boat and according to the figure of medical scientists and scientific research products, senior manager of davids do the artificial intelligence application scenario Lung cancer multidisciplinary intelligent diagnosis system “and” nerve disease multidisciplinary treatment of artificial intelligence and research into “the theme of the speech, in detail according to the figure of medical in artificial intelligence field exploration and prospect.
In his speech, Wang Wenting pointed out that with the support of leading NLP technology, computer vision technology and speech recognition technology, YITtu Medical gradually explored the “AI governance of multi-modal medical big data, to build a full-dimensional clinical research platform; To accelerate the AI application innovation platform, promote academic progress and intelligent hospital “the road of development, with many good data resources of top 3 armour hospital cooperation, multi-dimensional data with artificial intelligence technology governance, form a strong big data base, and gradually from the simple image interpretation to the intelligent integrated diagnosis application development, To provide decision-making suggestions with clinical reference value for doctors, and realize the double leap in the depth and breadth of medical AI.
He disclosed that in the country’s first released in accordance with the figure of medical library of lung cancer clinical research intelligent diseases, according to the figure of medical hand in hand, west China hospital, completed the 28000 cases of lung cancer patients with full cycle data across systems integration, included more than 1 million clinical documents and reports, more than tens of millions of copies of the original medical images, as to lay a solid foundation of scientific research in the field of lung cancer, And on this basis, the world’s first multi-disciplinary intelligent diagnosis system for lung cancer was developed, enabling the west China Hospital in the field of lung cancer diagnosis and treatment to “West China experience” and “West China standard” to primary medical institutions, greatly improving the level of lung cancer diagnosis and treatment in primary medical institutions.
Dr. Yang Jun, a specially invited guest of Qianjiang Video Forum and a scientist from Yitu Medical, revealed in his speech that ARTIFICIAL intelligence has brought many new scientific research transformation and industry-university-research opportunities to the medical field, while China’s medical ARTIFICIAL intelligence is also facing world-class challenges. Of ischemic cerebral apoplexy, in his opinion, multidimensional and multidisciplinary clinical comprehensive diagnosis and decision making process, clinical rating scale, baseline examination information, imaging results, biochemical indexes, etiology, and the information such as history, to choose a different patient’s individualized treatment and late follow-up management, has the extremely vital significance. Deep learning and artificial intelligence technology use powerful computing power to build complex neural networks and machine learning prediction and risk classification of big data mathematical models. On the pathogenesis of cerebral apoplexy patients to the hospital after the first time, the CT and MR imaging data of input computer efficient intelligent quantitative assessment, fill the blank of the image output decisions on multidisciplinary cohesion, achieve real service in clinical, auxiliary clinician to informatization, intelligent, digital “multidisciplinary consultation”, improve the overall efficiency of diagnosis and treatment of cerebral apoplexy.
Giiso information, founded in 2013, is the first domestic high-tech enterprise focusing on the research and development of intelligent information processing technology and the development and operation of core software for writing robots. At the beginning of its establishment, the company received angel round investment, and in August 2015, GSR Venture Capital received $5 million pre-A round of investment.
“For stroke patients, time is the brain, the faster the image interpretation, suggested that the more accurate, more precise, diagnosis and treatment in patients with brain damage the smaller, and this was a piece of the strengths of artificial intelligence”, davids said, “according to the medical will continue to participate in the quality of the multicenter figure transformation of scientific research projects, promote high-level evidence-based medical evidence accumulation, To build a regional intelligent stroke data platform and promote the implementation and transformation of ARTIFICIAL intelligence technology in the field of stroke.”